GlassScriptPhysician profile
Hina Saeed
NPI 1265708606
$1,939.29
in general payments reported to CMS, 2019-2025
14 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2021: $81.28 · 2022: $487 · 2023: $123 · 2024: $542 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,154.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $422.75 | 2019-2024 | |
| Palette Life Sciences, INC. | $250.74 | 2022-2023 | |
| Viewray Technologies INC | $201.82 | 2022 | |
| Medtronic, INC. | $163.68 | 2025 | Synchromedii |
| Icotec Medical INC. | $153.64 | 2024 | Icotec Blackarmor Spine System |
| Argon Medical Devices, INC. | $150.95 | 2025 | Clot Management |
| Gt Medical Technologies, INC | $142.29 | 2022 | |
| Janssen Biotech, INC. | $125.55 | 2024 | Erleada, Akeega |
| Cerapedics INC. | $112.61 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Novocure INC. | $89.96 | 2024-2025 | Optune, Optune Lua (Novottf-200t) |
| Accuray Incorporated | $67.84 | 2024 | |
| Reflexion Medical, INC. | $24.75 | 2025 | Reflexion Medical Radiotherapy System |
| Blue Earth Diagnostics | $17.24 | 2025 | Posluma |
| Seagen INC. | $15.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hina Saeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.